Tobramycin treatment of pseudomonas aeruginosa infections in cystic fibrosis

Scand J Infect Dis. 1974;6(4):333-7. doi: 10.3109/inf.1974.6.issue-4.07.
No abstract available

MeSH terms

  • Absorption
  • Adolescent
  • Aminoglycosides / administration & dosage
  • Aminoglycosides / adverse effects
  • Aminoglycosides / blood
  • Aminoglycosides / therapeutic use*
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / therapeutic use*
  • Child
  • Chronic Disease
  • Cystic Fibrosis / drug therapy*
  • Female
  • Humans
  • Injections, Intramuscular
  • Male
  • Pseudomonas Infections / drug therapy
  • Pseudomonas aeruginosa / drug effects*
  • Respiratory Therapy
  • Respiratory Tract Infections / drug therapy
  • Sputum / microbiology
  • Time Factors

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents